Amrutanjan Health Care Ltd Stock Price Today (NSE: AMRUTANJAN)
Fundamental Score
Amrutanjan Health Care Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Amrutanjan Health Care Ltd share price today is ₹533.75, down 1.39% on NSE/BSE as of 17 June 2026. Amrutanjan Health Care Ltd (AMRUTANJAN) is a Small-cap company in the Pharmaceuticals sector with a market capitalisation of ₹1.97K (Cr). The 52-week high for AMRUTANJAN share price is ₹790.95 and the 52-week low is ₹486.00. At a P/E ratio of 34.82x, AMRUTANJAN is currently trading above its industry average P/E of 31.77x. The company has a Return on Equity (ROE) of 16.53% and a debt-to-equity ratio of 0.01.
Amrutanjan Health Care Ltd Share Price Chart — NSE/BSE Historical Performance
Amrutanjan Health Care Ltd share price chart: -2.98% return over the past month. 52-week high ₹790.95, 52-week low ₹486.00.
Amrutanjan Health Care Ltd — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹555.65 | ₹565.00 | ₹550.05 | ₹555.85 | 21.25K (Cr) | |
| ₹566.95 | ₹566.95 | ₹541.65 | ₹559.85 | 24.89K (Cr) | |
| ₹559.95 | ₹567.00 | ₹552.00 | ₹558.65 | 25.99K (Cr) | |
| ₹556.00 | ₹564.50 | ₹554.15 | ₹559.95 | 8.34K (Cr) | |
| ₹562.85 | ₹567.95 | ₹556.05 | ₹557.75 | 11.79K (Cr) | |
| ₹555.60 | ₹572.40 | ₹555.00 | ₹562.85 | 24.96K (Cr) | |
| ₹551.35 | ₹560.05 | ₹541.60 | ₹557.20 | 22.02K (Cr) | |
| ₹555.95 | ₹555.95 | ₹547.00 | ₹549.25 | 17.96K (Cr) | |
| ₹555.00 | ₹555.00 | ₹546.05 | ₹550.50 | 8.58K (Cr) | |
| ₹557.00 | ₹562.90 | ₹551.40 | ₹557.35 | 10.72K (Cr) |
Amrutanjan Health Care Ltd — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹566.95 | ₹566.95 | ₹541.65 | ₹555.85 | -1.96% | |
| ₹570.00 | ₹598.00 | ₹530.30 | ₹558.65 | -1.99% | |
| ₹501.00 | ₹588.00 | ₹489.25 | ₹571.20 | +14.01% | |
| ₹580.00 | ₹590.75 | ₹486.00 | ₹493.65 | -14.89% | |
| ₹570.10 | ₹657.00 | ₹568.75 | ₹596.75 | +4.67% | |
| ₹668.55 | ₹676.50 | ₹575.00 | ₹583.75 | -12.68% | |
| ₹680.20 | ₹705.45 | ₹627.60 | ₹668.55 | -1.71% | |
| ₹720.60 | ₹744.00 | ₹679.00 | ₹680.95 | -5.50% | |
| ₹712.00 | ₹760.15 | ₹693.55 | ₹724.10 | +1.70% | |
| ₹691.30 | ₹790.95 | ₹691.30 | ₹713.60 | +3.23% | |
| ₹670.00 | ₹739.90 | ₹651.10 | ₹692.20 | +3.31% | |
| ₹715.20 | ₹754.00 | ₹653.00 | ₹660.20 | -7.69% |
AI Research Briefing
Powered by Gemini · 2026-04-15
Richly valued small-cap OTC player with limited catalysts and diversification risks.
WHAT'S HAPPENING NOW (last 2-4 weeks)
Amrutanjan Health Care responded to NSE queries regarding a news article and court order, clarifying it was an old 2005 case with no material impact. The stock hit a 52-week low of on March 23, 2026, amid broader market weakness. Q3 results showed EBITDA growth to M from M year-over-year, but EBITDA margin compressed to 17.85% from 19.02%.
CORE STORY (THE REAL GAME)
Amrutanjan is trying to transition from a pure pain balm play to a broader OTC and women's hygiene company, but the market isn't buying the story yet. They're still viewed as a one-trick pony despite efforts in beverages and hygiene.
- Q3 EBITDA growth, but margin compression
- NSE clarification on old court case
- 52-week low hit recently
- Successful launch of new women's hygiene products
- Acquisition by a larger pharma player
- Significant increase in FII/DII holdings
- Small-cap: liquidity risk
- Rich valuation: P/E above industry average
- Diversification risk: lack of focus
FII holdings slightly decreased, DII holdings slightly increased.
India Pharma 2026 calls for enhanced funding and innovation.
Yes, Free Cash Flow 5Y is ₹165.83 Cr.
Need to see significant traction in non-pain balm segments to justify valuation. Next 6 months are critical for diversification strategy.
Primary Thesis Risk
Failure to diversify beyond pain balms will lead to de-rating.
For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Amrutanjan Health Care Ltd Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Amrutanjan Health Care Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of AMRUTANJAN across key market metrics for learning purposes.
Positive Indicators
9 factors identified
Strong Return on Equity (16.53%)
Observation: Efficient use of shareholders' capital generating superior returns.
Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.
Excellent ROCE Performance (22.45%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.
Strong Operating Margins (15.52%)
Observation: Healthy 5-year operating margins indicate pricing power and cost control.
Analysis: OPM >15% suggests operational efficiency and competitive advantages.
Excellent EPS Growth (15.43% CAGR)
Observation: Outstanding 5-year earnings per share compound growth.
Analysis: EPS CAGR >15% indicates strong wealth creation potential.
Strong Profit Growth Track Record (15.18% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Conservative Debt Levels (D/E: 0.01)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Strong Interest Coverage (387.75x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Strong Cash Generation (₹165.83 Cr over 5Y)
Observation: Healthy free cash flow generation supports growth and returns.
Analysis: Strong FCF provides flexibility for dividends, debt reduction, and growth investments.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
0 factors identified
No significant concerns identified in current analysis.
Amrutanjan Health Care Ltd vs Pharmaceuticals Peers
Peer Comparison - Pharmaceuticals
Compare Amrutanjan Health Care Ltd with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Amrutanjan Health Care LtdAmrutanjan Heal...Selected✓ AMRUTANJAN • 590006 | 60.1/100 | ₹533.75₹534 | ₹1974.30₹1974.30 | 34.82Average 34.8 Average | 16.53%Good 16.53% Good | 22.45%Excellent 22.45% Excellent | 0.01Excellent 0.0 Excellent | 15.18%Excellent 15.18% Excellent | 11.56%Good 11.56% Good | 0.67% |
Sun Pharmaceutical Industries LtdSun Pharmaceuti... SUNPHARMA • 524715 | 65.2/100 | ₹1844.30₹1844 | ₹433738.68₹433738.68 | 37.57Average 37.6 Average | 16.86%Good 16.86% Good | 20.21%Excellent 20.21% Excellent | 0.07Excellent 0.1 Excellent | 23.78%Excellent 23.78% Excellent | 9.87%Good 9.87% Good | 0.89% |
Divis Laboratories LtdDivis Laborator... DIVISLAB • 532488 | 67.9/100 | ₹6797.50₹6798 | ₹170445.88₹170445.88 | 68.59Average 68.6 Average | 15.35%Good 15.35% Good | 20.44%Excellent 20.44% Excellent | 0.01Excellent 0.0 Excellent | 10.41%Good 10.41% Good | 11.65%Good 11.65% Good | 0.47% |
Torrent Pharmaceuticals LtdTorrent Pharmac... TORNTPHARM • 500420 | 65.3/100 | ₹4537.80₹4538 | ₹126430.62₹126430.62 | 58.36Average 58.4 Average | 26.52%Excellent 26.52% Excellent | 27.05%Excellent 27.05% Excellent | 0.33Excellent 0.3 Excellent | 13.84%Good 13.84% Good | 7.72%Good 7.72% Good | 0.86% |
Cipla LtdCipla Ltd... CIPLA • 500087 | 59/100 | ₹1418.20₹1418 | ₹123059.76₹123059.76 | 22.62Average 22.6 Average | 17.77%Good 17.77% Good | 22.72%Excellent 22.72% Excellent | 0.01Excellent 0.0 Excellent | 28.68%Excellent 28.68% Excellent | 9.97%Good 9.97% Good | 0.85% |
Dr Reddys Laboratories LtdDr Reddys Labor... DRREDDY • 500124 | 59.2/100 | ₹1319.00₹1319 | ₹105224.96₹105224.96 | 18.23Average 18.2 Average | 17.96%Good 17.96% Good | 22.69%Excellent 22.69% Excellent | 0.16Excellent 0.2 Excellent | 22.28%Excellent 22.28% Excellent | 13.26%Good 13.26% Good | 0.63% |
Lupin LtdLupin Ltd... LUPIN • 500257 | 66.7/100 | ₹2276.40₹2276 | ₹95148.15₹95148.15 | 22.00Average 22.0 Average | 20.62%Excellent 20.62% Excellent | 21.30%Excellent 21.30% Excellent | 0.32Excellent 0.3 Excellent | 54.88%Excellent 54.88% Excellent | 8.11%Good 8.11% Good | 0.58% |
Zydus Lifesciences LtdZydus Lifescien... ZYDUSLIFE • 532321 | 68.7/100 | ₹956.95₹957 | ₹94253.78₹94253.78 | 18.74Average 18.7 Average | 21.21%Excellent 21.21% Excellent | 24.31%Excellent 24.31% Excellent | 0.38Excellent 0.4 Excellent | 25.92%Excellent 25.92% Excellent | 10.27%Good 10.27% Good | 1.17% |
Mankind Pharma LtdMankind Pharma ... MANKIND • 543904 | 50.6/100 | ₹2420.40₹2420 | ₹92012.53₹92012.53 | 52.62Average 52.6 Average | 14.68%Average 14.68% Average | 15.98%Good 15.98% Good | 0.55Good 0.6 Good | 11.73%Good 11.73% Good | 15.79%Excellent 15.79% Excellent | 0.04% |
Aurobindo Pharma LtdAurobindo Pharm... AUROPHARMA • 524804 | 28.8/100 | ₹1435.90₹1436 | ₹70798.69₹70798.69 | 20.69Average 20.7 Average | 11.08%Average 11.08% Average | 14.18%Average 14.18% Average | 0.22Excellent 0.2 Excellent | 3.87%Average 3.87% Average | 6.55%Good 6.55% Good | 0.33% |
Alkem Laboratories LtdAlkem Laborator... ALKEM • 539523 | 59.5/100 | ₹5451.50₹5452 | ₹67075.29₹67075.29 | 28.54Average 28.5 Average | 19.39%Good 19.39% Good | 20.38%Excellent 20.38% Excellent | 0.18Excellent 0.2 Excellent | 13.93%Good 13.93% Good | 9.21%Good 9.21% Good | 0.80% |
Top Pharmaceuticals Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Sun Pharmaceutical Industries Ltd share price433738.68 Cr
- Divis Laboratories Ltd share price170445.88 Cr
- Torrent Pharmaceuticals Ltd share price126430.62 Cr
- Cipla Ltd share price123059.76 Cr
- Dr Reddys Laboratories Ltd share price105224.96 Cr
Amrutanjan Health Care Ltd PE Ratio History
Historical price-to-earnings ratio for AMRUTANJAN — last 5 years
| Year | EPS (₹) | Price (₹) | P/E Ratio |
|---|---|---|---|
| FY 2025 | ₹17.58 | ₹668.55 | 38x |
| FY 2024 | ₹15.50 | ₹722.65 | 46.6x |
| FY 2023 | ₹13.63 | ₹599.45 | 44x |
| FY 2022 | ₹22.98 | ₹710.60 | 30.9x |
P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.
Amrutanjan Health Care Ltd Dividend History
Annual cash dividends paid by AMRUTANJAN — dividend yield 0.67%
| Financial Year | Dividends Paid (₹ Cr) |
|---|---|
| FY 2025 | ₹13.27 Cr |
| FY 2024 | ₹13.39 Cr |
| FY 2023 | ₹14.41 Cr |
| FY 2022 | ₹12.48 Cr |
Cash dividends from annual cash flow statements. Past dividends do not guarantee future payments. Not investment advice.
Amrutanjan Health Care Ltd Quarterly Performance
Latest quarterly metrics for AMRUTANJAN — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
7.08%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
18.31%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
11.56%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
15.18%
Compounded annual net profit growth over 5 years
Amrutanjan Health Care Ltd Technical Indicators
SMA 50, SMA 200, RSI and volume signals for AMRUTANJAN — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Amrutanjan Health Care Ltd Financial Statements
Annual income statement, balance sheet and cash flow for Amrutanjan Health Care Ltd (AMRUTANJAN) — sourced from NSE/BSE filings.
Loading Financial Statements...
Fetching financial data for Amrutanjan Health Care Ltd
About AMRUTANJAN (Amrutanjan Health Care Ltd)
Amrutanjan Health Care Ltd is a venerable Indian pharmaceutical company steeped in tradition, yet dynamically evolving to meet modern healthcare needs. Born from a legacy of Ayurve...dic principles, they craft time-honored remedies designed to alleviate pain and promote wellness. Their familiar yellow tins and distinctive aromas are a household staple, instantly recognizable as a source of comfort and relief from everyday aches and pains. Beyond traditional balms, Amrutanjan has expanded its portfolio to include innovative pain management solutions, adapting to changing consumer preferences and leveraging scientific advancements to enhance efficacy. This commitment to both heritage and innovation positions Amrutanjan as a trusted brand with a contemporary edge. The company's operations span a diverse range of healthcare segments, reflecting a dedication to holistic well-being. From soothing pain balms and convenient roll-ons designed for on-the-go relief, to specialized products addressing joint and muscle discomfort, Amrutanjan caters to a broad spectrum of consumer needs. Recognizing the importance of hygiene and wellness, they've also ventured into the realm of hand sanitizers, providing protection in an increasingly health-conscious world. This strategic diversification highlights Amrutanjan's ability to adapt to market trends and expand its reach beyond traditional pain relief products, demonstrating a forward-thinking approach to business development. Amrutanjan's commitment extends beyond pharmaceuticals, venturing into the beverage sector with offerings that focus on health and hydration. This expansion signifies a strategic move towards preventative wellness, complementing their existing pain relief products. By providing consumers with choices that promote overall well-being, Amrutanjan is solidifying its position as a holistic healthcare provider. This diversified approach, combining traditional remedies, innovative pain management solutions, and wellness-focused beverages, reinforces Amrutanjan's commitment to improving the lives of its consumers, both within India and on an international stage.
Company Details
Key Leadership
Corporate Events
AMRUTANJAN Share Price: Frequently Asked Questions
What is the current share price of Amrutanjan Health Care Ltd?
Amrutanjan Health Care Ltd (AMRUTANJAN) trades at ₹533.75 on NSE and BSE. Market cap ₹1.97K (Cr). Educational data only.
What is the P/E ratio of Amrutanjan Health Care Ltd?
Amrutanjan Health Care Ltd has a P/E of 34.82x vs industry average 31.77x.
What is the Bull Run score for Amrutanjan Health Care Ltd?
Amrutanjan Health Care Ltd has a Bull Run score of 60.1/100 based on 25+ financial parameters.
Does Amrutanjan Health Care Ltd pay dividends?
Amrutanjan Health Care Ltd has a dividend yield of 0.67%. Past dividends don't guarantee future payments.
What is the ROE of Amrutanjan Health Care Ltd?
Amrutanjan Health Care Ltd has ROE of 16.53%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Amrutanjan Health Care Ltd?
Amrutanjan Health Care Ltd has debt-to-equity of 0.01.
Is Amrutanjan Health Care Ltd a good investment?
Bull Run gives Amrutanjan Health Care Ltd a score of 60.1/100. This is not investment advice — consult a SEBI-registered advisor.